Stocks · Health care · Pharmaceutical Preparations

AN2 Therapeutics, Inc.

ANTX Clue Score37
United States Fiscal year ends December CIK 0001880438 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Robin Shane Readnour
9 Sep 2026
Director
Sold on a plan indirect
585
$6.02
$3.52K
Robin Shane Readnour
9 Sep 2026
Director
Sold on a plan indirect
523
$6.02
$3.15K
Robin Shane Readnour
8 Sep 2026
Director
Sold on a plan indirect
5,294
$6.02
$31.86K
Robin Shane Readnour
8 Sep 2026
Director
Sold on a plan indirect
4,725
$6.02
$28.44K
Robin Shane Readnour
3 Sep 2026
Director
Sold on a plan indirect
3,223
$6.07
$19.56K
Robin Shane Readnour
3 Sep 2026
Director
Sold on a plan indirect
2,877
$6.07
$17.46K
Margaret M FitzPatrick
1 Sep 2026
Director
Buy
2,098
$5.53
$11.60K
Sarah Joanne Williams
1 Sep 2026
Principal Accounting Officer
Sell
272
$5.53
$1.50K
Robin Shane Readnour
17 Aug 2026
Director
Sold on a plan indirect
18,706
$6.01
$112.39K
Robin Shane Readnour
17 Aug 2026
Director
Sold on a plan indirect
16,696
$6.01
$100.31K
Joshua M Eizen
8 Jul 2026
See Remarks
Sell
5,945
$4.17
$24.80K
Sarah Joanne Williams
29 May 2026
Principal Accounting Officer
Sell
265
$4.43
$1.17K
Sarah Joanne Williams
3 Mar 2026
Principal Accounting Officer
Sell
327
$1.06
$346.62
Joshua M Eizen
6 Jan 2026
See Remarks
Sell
6,931
$1.01
$7.01K
Sanjay Chanda
6 Jan 2026
Chief Development Officer
Sell
5,956
$1.01
$6.03K
Stephen David Prior
6 Jan 2026
Chief Strategy Officer
Sell
2,858
$1.01
$2.89K
Lucy Day
6 Jan 2026
Chief Financial Officer
Sell
5,512
$1.01
$5.58K
Joshua M Eizen
5 Jan 2026
See Remarks
Sell
17,923
$1.00
$17.95K
Sanjay Chanda
5 Jan 2026
Chief Development Officer
Sell
3,295
$1.00
$3.30K
Stephen David Prior
5 Jan 2026
Chief Strategy Officer
Sell
3,604
$1.00
$3.61K
Lucy Day
5 Jan 2026
Chief Financial Officer
Sell
3,295
$1.00
$3.30K
Stephen David Prior
4 Nov 2025
Chief Strategy Officer
Sell
765
$1.14
$872.10
Joshua M Eizen
4 Nov 2025
See Remarks
Sell
2,819
$1.14
$3.21K
Eric Easom
2 Jun 2025
Chief Executive Officer
Buy
10,000
$1.07
$10.67K
Braden Michael Leonard
30 May 2025
10% owner
Sell indirect
7,000
$1.03
$7.23K
Braden Michael Leonard
30 May 2025
10% owner
Sell indirect
425,000
$1.01
$429.25K
Margaret M FitzPatrick
28 May 2025
Director
Buy
8,610
$1.18
$10.13K
Braden Michael Leonard
28 May 2025
10% owner
Sell indirect
100,000
$1.16
$116.00K
Braden Michael Leonard
28 May 2025
10% owner
Sell indirect
2,000,000
$1.16
$2.32M
Braden Michael Leonard
28 May 2025
10% owner
Sell indirect
200,000
$1.09
$218.00K
Joshua M Eizen
3 Jan 2025
See Remarks
Sell
9,663
$1.34
$12.96K
Stephen David Prior
3 Jan 2025
Chief Strategy Officer
Sell
2,029
$1.34
$2.72K
Sanjay Chanda
3 Jan 2025
Chief Development Officer
Sell
2,957
$1.34
$3.97K
Lucy Day
3 Jan 2025
Chief Financial Officer
Sell
2,957
$1.34
$3.97K
Robin Shane Readnour
10 Dec 2024
Director
Buy indirect
5,000
$1.49
$7.47K
Robin Shane Readnour
10 Dec 2024
Director
Buy indirect
5,000
$1.49
$7.46K
Robin Shane Readnour
9 Dec 2024
Director
Buy indirect
18,483
$1.43
$26.41K
Robin Shane Readnour
9 Dec 2024
Director
Buy indirect
12,289
$1.43
$17.58K
Robin Shane Readnour
6 Dec 2024
Director
Buy indirect
6,517
$1.45
$9.43K
Robin Shane Readnour
6 Dec 2024
Director
Buy indirect
12,711
$1.45
$18.37K
Joseph S Zakrzewski
27 Nov 2024
Director
Buy
2,000
$1.40
$2.80K
Robin Shane Readnour
27 Nov 2024
Director
Buy indirect
25,000
$1.42
$35.42K
Robin Shane Readnour
27 Nov 2024
Director
Buy indirect
25,000
$1.42
$35.42K
Robin Shane Readnour
26 Nov 2024
Director
Buy indirect
12,500
$1.39
$17.43K
Robin Shane Readnour
26 Nov 2024
Director
Buy indirect
12,500
$1.39
$17.42K
Robin Shane Readnour
20 Nov 2024
Director
Buy indirect
25,000
$1.15
$28.87K
Robin Shane Readnour
20 Nov 2024
Director
Buy indirect
25,000
$1.16
$29.00K
Joseph S Zakrzewski
19 Nov 2024
Director
Buy
5,000
$1.01
$5.05K
Robin Shane Readnour
19 Nov 2024
Director
Buy indirect
75,000
$1.04
$77.73K
Robin Shane Readnour
19 Nov 2024
Director
Buy indirect
75,000
$1.03
$77.53K
Eric Easom
18 Nov 2024
Chief Executive Officer
Buy indirect
50,000
$1.00
$49.97K
Joseph S Zakrzewski
18 Nov 2024
Director
Buy
20,000
$1.00
$20.00K
Braden Michael Leonard
14 Aug 2024
10% owner
Buy indirect
1,500,000
$1.04
$1.56M
Ra Capital Management, L.p.
9 Aug 2024
10% owner
Sell indirect
114,759
$1.08
$123.94K
Ra Capital Management, L.p.
9 Aug 2024
10% owner
Sell indirect
3,410,335
$1.08
$3.68M
Joseph S Zakrzewski
18 Jan 2024
Director
Sell indirect
100,000
$19.11
$1.91M
Adjuvant Global Health Technology Fund, L.P.
16 Jan 2024
10% owner
Sell indirect
15,907
$19.65
$312.57K
Adjuvant Global Health Technology Fund, L.P.
16 Jan 2024
10% owner
Sell
84,093
$19.65
$1.65M
Kabeer Aziz
16 Jan 2024
Director
Sell indirect
15,907
$19.65
$312.57K
Kabeer Aziz
16 Jan 2024
Director
Sell indirect
84,093
$19.65
$1.65M
Robin Shane Readnour
12 Jan 2024
Director
Sold on a plan indirect
719
$21.91
$15.75K
Robin Shane Readnour
12 Jan 2024
Director
Sold on a plan indirect
706
$21.92
$15.48K
Robin Shane Readnour
10 Jan 2024
Director
Sold on a plan indirect
1,800
$21.92
$39.46K
Robin Shane Readnour
10 Jan 2024
Director
Sold on a plan indirect
1,869
$21.93
$40.99K
Kevin Michael Krause
9 Jan 2024
Chief Strategy Officer
Sold after exercise
7,417
$20.14
$149.37K
Eric Easom
2 Jan 2024
Chief Executive Officer
Sold on a plan
2,777
$20.09
$55.80K
Kevin Michael Krause
2 Jan 2024
Chief Strategy Officer
Sold after exercise
2,583
$20.12
$51.97K
Kabeer Aziz
14 Nov 2023
Director
Sold on a plan indirect
288
$16.15
$4.65K
Kabeer Aziz
14 Nov 2023
Director
Sold on a plan indirect
1,522
$16.15
$24.57K
Adjuvant Global Health Technology Fund, L.P.
14 Nov 2023
10% owner
Sold on a plan indirect
288
$16.15
$4.65K
Adjuvant Global Health Technology Fund, L.P.
14 Nov 2023
10% owner
Sold on a plan
1,522
$16.15
$24.57K
Adjuvant Global Health Technology Fund, L.P.
2 Oct 2023
10% owner
Sell indirect
902
$16.07
$14.50K
Adjuvant Global Health Technology Fund, L.P.
2 Oct 2023
10% owner
Sell
4,770
$16.07
$76.65K
Kabeer Aziz
2 Oct 2023
Director
Sell indirect
902
$16.07
$14.50K
Kabeer Aziz
2 Oct 2023
Director
Sell indirect
4,770
$16.07
$76.65K
Adjuvant Global Health Technology Fund, L.P.
29 Sep 2023
10% owner
Sell indirect
15,764
$16.28
$256.64K
Adjuvant Global Health Technology Fund, L.P.
29 Sep 2023
10% owner
Sell
83,337
$16.28
$1.36M
Kabeer Aziz
29 Sep 2023
Director
Sell indirect
15,764
$16.28
$256.64K
Kabeer Aziz
29 Sep 2023
Director
Sell indirect
83,337
$16.28
$1.36M
Kabeer Aziz
28 Sep 2023
Director
Sell indirect
1,356
$16.11
$21.85K
Kabeer Aziz
28 Sep 2023
Director
Sell indirect
7,160
$16.11
$115.35K
Adjuvant Global Health Technology Fund, L.P.
28 Sep 2023
10% owner
Sell indirect
1,356
$16.11
$21.85K
Adjuvant Global Health Technology Fund, L.P.
28 Sep 2023
10% owner
Sell
7,160
$16.11
$115.35K
Kabeer Aziz
27 Sep 2023
Director
Sell indirect
134
$16.07
$2.15K
Kabeer Aziz
27 Sep 2023
Director
Sell indirect
707
$16.07
$11.36K
Adjuvant Global Health Technology Fund, L.P.
27 Sep 2023
10% owner
Sell indirect
134
$16.07
$2.15K
Adjuvant Global Health Technology Fund, L.P.
27 Sep 2023
10% owner
Sell
707
$16.07
$11.36K
Adjuvant Global Health Technology Fund, L.P.
13 Sep 2023
10% owner
Sell indirect
64
$16.00
$1.02K
Adjuvant Global Health Technology Fund, L.P.
13 Sep 2023
10% owner
Sell
336
$16.00
$5.38K
Kabeer Aziz
13 Sep 2023
Director
Sell indirect
64
$16.00
$1.02K
Kabeer Aziz
13 Sep 2023
Director
Sell indirect
336
$16.00
$5.38K
Kabeer Aziz
7 Sep 2023
Director
Sell indirect
537
$16.05
$8.62K
Kabeer Aziz
7 Sep 2023
Director
Sell indirect
2,841
$16.05
$45.60K
Adjuvant Global Health Technology Fund, L.P.
7 Sep 2023
10% owner
Sell indirect
537
$16.05
$8.62K
Adjuvant Global Health Technology Fund, L.P.
7 Sep 2023
10% owner
Sell
2,841
$16.05
$45.60K
Kabeer Aziz
6 Sep 2023
Director
Sell indirect
598
$16.02
$9.58K
Kabeer Aziz
6 Sep 2023
Director
Sell indirect
3,164
$16.02
$50.69K
Adjuvant Global Health Technology Fund, L.P.
6 Sep 2023
10% owner
Sell indirect
598
$16.02
$9.58K
Adjuvant Global Health Technology Fund, L.P.
6 Sep 2023
10% owner
Sell
3,164
$16.02
$50.69K
Kabeer Aziz
23 Aug 2023
Director
Sell indirect
64
$16.00
$1.02K
Kabeer Aziz
23 Aug 2023
Director
Sell indirect
336
$16.00
$5.38K
Adjuvant Global Health Technology Fund, L.P.
23 Aug 2023
10% owner
Sell indirect
64
$16.00
$1.02K
Adjuvant Global Health Technology Fund, L.P.
23 Aug 2023
10% owner
Sell
336
$16.00
$5.38K
Ra Capital Management, L.p.
18 Aug 2023
10% owner
Buy indirect
1,777,778
$9.00
$16.00M
Eric Easom
15 May 2023
Chief Executive Officer
Buy indirect
10,000
$5.38
$53.77K
Eric Easom
14 Nov 2022
Chief Executive Officer
Sell
23
$15.04
$345.92
Eric Easom
10 Nov 2022
Chief Executive Officer
Sell
4,413
$15.32
$67.63K
Eric Easom
9 Nov 2022
Chief Executive Officer
Sell
10,111
$15.61
$157.85K
Eric Easom
8 Nov 2022
Chief Executive Officer
Sell
1,255
$16.38
$20.56K
Eric Easom
8 Nov 2022
Chief Executive Officer
Sell
5,800
$15.41
$89.39K
Eric Easom
7 Nov 2022
Chief Executive Officer
Sell
2,036
$16.72
$34.04K
Eric Easom
7 Nov 2022
Chief Executive Officer
Sell
10,167
$15.90
$161.71K
Eric Easom
4 Nov 2022
Chief Executive Officer
Sell
8,828
$15.80
$139.47K
Eric Easom
3 Nov 2022
Chief Executive Officer
Sell
3,083
$16.02
$49.38K
Eric Easom
3 Nov 2022
Chief Executive Officer
Sell
11,082
$15.67
$173.68K
Eric Easom
2 Nov 2022
Chief Executive Officer
Sell
1,544
$15.07
$23.26K
Eric Easom
31 Oct 2022
Chief Executive Officer
Sell
2,688
$15.39
$41.36K
Eric Easom
28 Oct 2022
Chief Executive Officer
Sell
1,683
$15.09
$25.39K
Eric Easom
27 Oct 2022
Chief Executive Officer
Sell
924
$15.36
$14.19K
Eric Easom
26 Oct 2022
Chief Executive Officer
Sell
1,678
$15.10
$25.34K
Eric Easom
25 Oct 2022
Chief Executive Officer
Sell
534
$16.20
$8.65K
Eric Easom
25 Oct 2022
Chief Executive Officer
Sell
4,272
$15.69
$67.02K
Eric Easom
24 Oct 2022
Chief Executive Officer
Sell
2,866
$16.17
$46.34K
Eric Easom
21 Oct 2022
Chief Executive Officer
Sell
2,350
$16.69
$39.23K
Eric Easom
21 Oct 2022
Chief Executive Officer
Sell
11,601
$16.29
$189.01K
Eric Easom
20 Oct 2022
Chief Executive Officer
Sell
31
$17.15
$531.50
Eric Easom
20 Oct 2022
Chief Executive Officer
Sell
7,262
$16.68
$121.14K
Ra Capital Management, L.p.
4 Aug 2022
10% owner
Buy indirect
100
$7.99
$799.00
Ra Capital Management, L.p.
3 Aug 2022
10% owner
Buy indirect
1,809
$7.48
$13.53K
Ra Capital Management, L.p.
27 Jul 2022
10% owner
Buy indirect
8,281
$7.91
$65.50K
Ra Capital Management, L.p.
26 Jul 2022
10% owner
Buy indirect
14,938
$7.71
$115.17K
Ra Capital Management, L.p.
21 Jun 2022
10% owner
Buy indirect
302
$7.99
$2.41K
Ra Capital Management, L.p.
14 Jun 2022
10% owner
Buy indirect
61,424
$7.97
$489.40K
Ra Capital Management, L.p.
13 Jun 2022
10% owner
Buy indirect
20,000
$7.90
$158.00K
Ra Capital Management, L.p.
29 Mar 2022
10% owner
Buy indirect
115,613
$15.00
$1.73M
Ra Capital Management, L.p.
29 Mar 2022
10% owner
Buy indirect
1,551,053
$15.00
$23.27M
Kabeer Aziz
29 Mar 2022
Director
Buy indirect
166,666
$15.00
$2.50M
Adjuvant Global Health Technology Fund, L.P.
29 Mar 2022
10% owner
Buy indirect
166,666
$15.00
$2.50M
Robin Shane Readnour
29 Mar 2022
Director
Buy indirect
82,618
$15.00
$1.24M
Robin Shane Readnour
29 Mar 2022
Director
Buy indirect
70,716
$15.00
$1.06M

What was left out

Form 4 filings counted 186
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 2
Sales at will 84
Transactions with no price 0
Shares from compensation/vesting 9,487,058
Sales filed before the plan box existed 22
History held since 31 Mar 2022